ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,541Medicare Part D Prescriptions Filled, Including Refills

Rank: 302 out of 972

$645K Total Retail Price of All Prescriptions

Rank: 181 out of 972

458 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,111 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 593 546 1 2
LISINOPRIL 381 350 2 1
AMLODIPINE BESYLATE 295 284 3 4
HYDROCODONE-ACETAMINOPHEN 267 185 S3 4 6
FUROSEMIDE 254 232 5 7
LEVOTHYROXINE SODIUM 247 221 6 3
METFORMIN HCL 221 198 7 8
OMEPRAZOLE 187 147 8 5
METOPROLOL TARTRATE 161 140 9 9
ATORVASTATIN CALCIUM 157 141 10 11
POTASSIUM CHLORIDE 117 98 11 13
GABAPENTIN 114 88 12 14
WARFARIN SODIUM 114 102 12 12
CIPROFLOXACIN HCL 108 91 14 63
ZOLPIDEM TARTRATE 105 71 15 23
DONEPEZIL HCL 105 105 15 26
MELOXICAM 102 80 17 36
METOPROLOL SUCCINATE 97 97 18 16
ALLOPURINOL 93 89 19 28
DICLOFENAC SODIUM 88 77 20 130
CLOPIDOGREL 86 79 21 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 78 22 32
HYDROCHLOROTHIAZIDE 82 76 23 10
CARVEDILOL 81 68 24 21
TAMSULOSIN HCL 79 63 25 29
TRAMADOL HCL 77 70 26 15
DOXAZOSIN MESYLATE 77 73 26 82
PLAVIX 76 72 28 55
ATENOLOL 75 71 29 18
TRIAMTERENE-HCTZ 73 71 30 39
CITALOPRAM HBR 73 72 30 19
ACTOS 72 62 32 163
GLIPIZIDE 71 69 33 59
FLUTICASONE PROPIONATE 71 52 33 31
AVODART 68 68 35 214
PANTOPRAZOLE SODIUM 66 59 36 41
CELEBREX 65 65 37 85
ROPINIROLE HCL 64 63 38 72
CYMBALTA 64 61 38 49
DIOVAN 63 54 40 48
LOSARTAN POTASSIUM 63 56 40 17
ADVAIR DISKUS 61 38 42 45
TOPIRAMATE 59 20 43 126
ISOSORBIDE MONONITRATE ER 59 47 43 43
FENOFIBRATE 57 54 45 66
AMITRIPTYLINE HCL 56 52 R 46 58
CRESTOR 55 48 47 33
ALENDRONATE SODIUM 53 51 48 27
OXYCODONE-ACETAMINOPHEN 52 38 S2 49 80
GEMFIBROZIL 52 39 49 93
CARBIDOPA-LEVODOPA 51 51 51 87
METHYLPREDNISOLONE 50 46 52 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.